The Effect of Progressive Relaxation Exercises and Planned Education on Menopausal Symptoms, Perceived Stress, and Anxiety in Menopausal Women

February 13, 2026 updated by: Sukran Ertekin Pinar, Cumhuriyet University
The Effect of Progressive Relaxation Exercises and Planned Education on Menopausal Symptoms, Perceived Stress, and Anxiety in Menopausal Women

Study Overview

Detailed Description

The study will be conducted with women who are in the menopausal period. Data will be collected using the Personal Information Form, Menopause Symptoms Assessment Scale, Perceived Stress Scale and Beck Anxiety Scale.

Study; It will be divided into three groups: progressive relaxation exercise group, planned training group and control group. A total of 144 participants, 48 for each group, were planned to be included in the sample.

Study Type

Interventional

Enrollment (Actual)

144

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Merkez
      • Sivas, Merkez, Turkey (Türkiye), 00058
        • Sivas Cumhuriyet University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Not having communication and perception problems
  • Being in menopause
  • Not having a mental illness diagnosis
  • Voluntary participation in the study

Exclusion Criteria:

  • Having communication and perception problems
  • Not being in menopause
  • Not having a mental illness diagnosis
  • Not being a volunteer to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: progressive relaxation exercise
Progressive relaxation exercises combine deep breathing with the contraction and relaxation of muscle groups such as the hands, arms, upper arms, feet, lower legs and calves, hips, abdomen and lower back, chest, face, shoulders and back, neck, jaw, lips, eyes, and forehead. After taking a deep breath, the muscles are tensed, this tension is maintained for 5-10 seconds, and then the muscles are relaxed (10-20 seconds). When a muscle is tense, the deeper the tension, the deeper the relaxation will be when it is released. During the exercise, the individual is asked to continue breathing in slowly and deeply through the nose and exhaling through the mouth.
Progressive relaxation exercises begin with breathing exercises and continue with muscle stretching and relaxation exercises, lasting an average of 30 minutes.
Experimental: planned education
The topics covered in the educational content include: What menopause is, causes of menopause, factors affecting the onset of menopause, complaints during menopause, general symptoms of menopause, nutrition during menopause, sleep during menopause, emotional problems during menopause, and coping strategies.
The training group will receive pre-planned training in accordance with the literature, delivered as group training in line with adult learning principles.
No Intervention: control group
The control group will not receive any intervention; only the Perceived Stress Scale, Menopause Symptom Assessment Scale, and Beck Anxiety Scale will be administered as pre-tests and post-tests.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perceived Stress Scale
Time Frame: Beginning
The scale consists of 10 items and is evaluated based on a total score. The scale is scored on a scale of 1-5. The total score ranges from 10 to 50, and an increase in the score indicates an increase in perceived stress level. The scale is assessed before any training or relaxation exercises during the initial encounter with women.
Beginning
Beck Anxiety Scale
Time Frame: Beginning
The scale ranges from a minimum of 0 to a maximum of 63 points. However, based on the scores obtained on the scale, patients' anxiety levels are classified as follows: 0-7 points is low, 8-15 points is mild, 16-25 points is moderate, and 26-63 points is high anxiety. A high score indicates that the individual is experiencing a high level of anxiety.The scale is assessed before any training or relaxation exercises during the initial encounter with women.
Beginning
Menopause Symptom Assessment Scale
Time Frame: Beginning
The scale consists of 11 items and 3 subscales. An increase in the total score obtained from the scale indicates an increase in the severity of complaints and, consequently, a negative impact on quality of life. The lowest possible score on the entire scale is 0, and the highest is 44.The scale is assessed before any training or relaxation exercises during the initial encounter with women.
Beginning

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perceived Stress Scale
Time Frame: One month after relaxation exercises and planned training practices
The scale consists of 10 items and is evaluated based on a total score. The scale is scored on a scale of 1-5. The total score ranges from 10 to 50, and an increase in the score indicates an increase in perceived stress level. The scale is administered to the women again one month after the planned training and relaxation exercises are implemented.
One month after relaxation exercises and planned training practices
Beck Anxiety Scale
Time Frame: One month after relaxation exercises and planned training practices
Description: The scale ranges from a minimum of 0 to a maximum of 63 points. However, based on the scores obtained on the scale, patients' anxiety levels are classified as follows: 0-7 points is low, 8-15 points is mild, 16-25 points is moderate, and 26-63 points is high anxiety. A high score indicates that the individual is experiencing a high level of anxiety.The scale is administered to the women again one month after the planned training and relaxation exercises are implemented.
One month after relaxation exercises and planned training practices
Menopause Symptom Assessment Scale
Time Frame: One month after relaxation exercises and planned training practices
Description: The scale consists of 11 items and 3 subscales. An increase in the total score obtained from the scale indicates an increase in the severity of complaints and, consequently, a negative impact on quality of life. The lowest possible score on the entire scale is 0, and the highest is 44.The scale is administered to the women again one month after the planned training and relaxation exercises are implemented.
One month after relaxation exercises and planned training practices

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sukran Ertekin Pinar, Cumhuriyet University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2026

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2026

Study Registration Dates

First Submitted

January 29, 2026

First Submitted That Met QC Criteria

February 13, 2026

First Posted (Actual)

February 17, 2026

Study Record Updates

Last Update Posted (Actual)

February 17, 2026

Last Update Submitted That Met QC Criteria

February 13, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anxiety

Clinical Trials on Progressive relaxation

Subscribe